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Background: Epidemiological data suggest that the prevalence of syphilis, gonorrhea and trichomoniasis has
increasedin bothurbanandruralareasof Mongolia.Thesedataareprimarily substantiatedby notifications of cases
ofclinically apparentdiseaseinbothruralandurbanareas,pluslaboratorydiagnosesfromtheAIDS/STDReference
Center,Ulaanbaatar. In the past5 years,however, there has been a marked decline in the total numberof patients
being screened for sexually transmitted infections (STIs). An assessment of true prevalence of STIs in a female
population attending an urban sexually transmitted diseases (STD) clinic was therefore commenced.
Methods: Consecutivewomen attending an STD clinic in Ulaanbaatar had genitalsamples collected by the inser-
tion and immediate removal of a tampon, which was then tested for the presence of Neisseria gonorrhoeae,
Chlamydia trachomatis, human papillomavirus (HPV) and Trichomonas vaginalis, using polymerase chain reaction
(PCR) amplification.
Results: A total of 110 women were studied (mean age 26.7 years). Overall, 58 (53%) patients had one or more
pathogens identified; 43 (39%) had a single pathogen, while 15 (14%) had mixed pathogens. C. trachomatis was
found in 15 (14%), N. gonorrhoeae in 12 (11%), T. vaginalis in nine (8%) and HPV in 39 (36%). Among the 39
HPV-positivepatients,oncogenicgenotypes(16,18,31,33,35,39,45,51,52)werefoundin17(44%)patients.
Conclusions: Sexually transmitted infections as defined by PCR were common, and found in 53% of female
attendees of an urban STD clinic in Mongolia. As infections with conventional STIs increase the risk of human
immunodeficiency virus(HIV) transmission,it is imperative that strategiesbe introducedto reducethe prevalence
of STIs. Furthermore, detection of oncogenic HPV was common, indicating that it is vital that a strategyto reduce
cervical cancer such as a pre-cancer cervical cytology screening program also be introduced.
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Mongolia is a sparsely populated (2.3 million)
country, with 600 000 people being concentrated
in the capital city of Ulaanbaatar, the only large
urban area. People within the rural area (as well as
40% of those living in the city) live in gers (also
called yurts), and a nomadic lifestyle is still
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Clinical study 143prevalent. In the past decade there have been
several changes in government, with independ-
ence from the former Soviet Union occurring in
September 1990. With the introduction of privat-
ization, travel abroad and loss of Soviet aid, there
has been anincrease inunemployment,alcoholism
and prostitution. Epidemiological data collected
bytheAIDS/STDReference Center, Ulaanbaatar
show a general increase in sexually transmissible
diseases, despite amarkeddeclinein totalscreening
(1983: gonorrhea 51 per 100 000 population,
1995: 142 per 100 000; trichomoniasis 47 per
100 000 vs. 155 per 100 000, respectively, for the
same years; and syphilis 18 per 100 000 in 1993 vs.
32 per 100 000 in 1995)1,2. These data are largely
obtainedfromnotified clinically diagnosed cases of
infection, plus laboratory diagnoses from clinically
suspected cases as sent to the Reference Center in
Ulaanbaatar. Resources for definitive diagnoses of
various sexually transmitted infections (STIs),
especially in rural areas, are very limited.
We have previously shown that patient-
administered tampons as a genital sampling tech-
nique for detection of STIs by polymerase chain
reaction (PCR) technology is an effective and
sensitive method for determining STI prevalence,
particularly when adapted to populations in
remote areas3–5. Therefore, this methodology was
adapted to determine the prevalence of various
STIs in female attendees of a sexually transmitted
diseases (STD) clinic in Ulaanbaatar, Mongolia.
METHODS
Study population
Consecutive women whoattended theSTD clinic
at the AIDS/STD Center, Ulaanbaatar, Mongolia
wereinvited totakepartinthestudy.Women may
have presented for a routine STI screen or for the
investigation of symptomatic disease.
Specimen collection
Prior to vaginal speculum examination, and after
consent was obtainedfrom eachwoman,a tampon
was inserted into the vagina, then immediately
removed and placed in PCR transport buffer
(0.14 mol/l NaCl, 3 mmol/l KCl, 10 mmol/l
Na2HPO4, 2 mmol/l KH2PO4). They were then
sent to the Molecular Laboratory of the
Microbiology Department, The Royal Women’s
Hospital, Melbourne, Australia for processing.
Samples were transported by air with a travel time
of 7 days. Tamponswere processed by initially dis-
lodging cells by squeezing, and subsequently
pelleting by centrifugation3. DNA was extracted
from 20-ml aliquots of tampon cell pellets using a
QIAamp DNA Purification Kit (Qiagen Inc.,
Chatsworth, CA as per the manufacturer’s
instructions.
Polymerase chain reaction
For human papillomavirus (HPV), each PCR
reaction consisted of a 20-ml aliquot of extracted
DNA (i.e. one-tenth of the total eluted DNA),
1 ´ reaction buffer (50 mmol/l KCl, 10 mmol/l
Tris pH 8.3), 200 mmol/l each of deoxyadenosine
triphosphate, deoxyguanosine triphosphate and
deoxycytidine triphosphate (dATP, dGTP and
dCTP) and 190 mmol/l deoxythymidine
triphosphate (dTTP), 10 mmol/l digoxigenin–
deoxyuridine triphosphate (dUTP) (Boehringer
Mannheim, Mannheim, Germany), 4 mmol/l
MgCl2, 50 pmol of L1 consensus primers
MY09–MY116, 5 pmol of b-globin primers
GH20–PCO47 and 2.5 units of AmpliTaq-Gold
polymerase8 (Perkin Elmer-Cetus, Norfolk, NJ)
in a total of 50 ml. The addition of digoxigenin–
dUTP allowed incorporation of digoxigenin in
amplicons during the amplification process.
b-Globin primers, which simultaneously
amplify ahumanb-globinproductof260 bp,were
included as a positive internal control. Generation
of an amplicon by this primer indicated the
presence of adequate amplifiable DNA.
The SiHa cell line (one copyof integrated HPV
16 per cell) and HEL cell line (human embryonic
lung, containing no HPV DNA) were used as
positive and negative controls, respectively.
Specimencontaminationandcarry-overwerepre-
vented by using positive displacement pipettes,
prior aliquoting of all reagents, and performing
pre- and post-PCR steps in different rooms
specifically allocated for PCR.
PCR products for the detection of HPV were
analyzed by a PCR enzyme-linked immuno-
sorbent assay (ELISA)-based detection system
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generic probe was produced by amplification as
described by Bauer and colleagues9. The
double-stranded 400-bp probe was denatured in
50 mmol/l NaOH, and subsequently added to a
5-ml aliquot of amplification product. Following a
10-min incubation, the denatured amplicon–
probe mixture was added to Streptavidin-coated
microtiter wells containing hybridization buffer
supplied with the PCR ELISA kit. After a 6-h
hybridization at 55°C the microtiter wells were
washed, and detection of specific hybrids deter-
mined at an absorbance of 405 mm (reference filter
492 mm); the extinction value of the blank was
subtracted as per the manufacturer’s instructions.
Positive samples were determined by the cut-off
value as described above. All HPV-positive
samples were typed by probing with the PCR
ELISA system using type-specific, biotin-labeled,
nested oligonucleotide probes for HPV 6, 11, 16,
18, 31, 33, 35, 39, 45, 51 and 52, as described by
Resnick and colleagues7. Sub-types not belonging
to this list were called ‘other types’. Samples show-
ing low-level positivity could not be typed, and
were labeled as ‘untypeable’.
Detection of Chlamydia trachomatis, Trichomonas
vaginalis and Neisseria gonorrhoeae amplicons was
performed as described previously5.
RESULTS
All 110 women invited to participate were
enrolledinthestudy.Themean age ofpatientswas
26.7 years. Overall, 58 (53%) women had an STI
pathogen detected (Table 1), and in 43 of these
(74%) only a single pathogen was detected. There
was no significant difference in mean age of these
women,comparedwiththosewithoutadetectable
pathogen.
With the exclusion of those with HPV alone,
37% (30/82) had C. trachomatis, N. gonorrhoeae
and/or T. vaginalis. Overall, for the population
studied, C. trachomatis was detected in 15 (14%),
N. gonorrhoeae in 12 (11%) and T. vaginalis in nine
(8%) women (Table 1).
In total, HPV was detected in 39/110 (36%)
women. HPV genotyping showed detection of
oncogenic HPV 16 or 18 in nine (23%); HPV 31,
33, 35or39 infour(10.3%); andHPV 45,51or52
in four (10.3%) patients. Overall, oncogenic HPV
was detected in 44% (17/39) of HPV-positive
women, with more than one genotype present in
four women. Low-risk HPV 6 and 11 were
detected in 18% (7/39) of HPV-positive patients.
Clinically, three of these patients had condyloma
accuminata, and all were HPV 6- or 11-positive.
DISCUSSION
Sexually transmitted infections N. gonorrhoeae,
C. trachomatis, T. vaginalis and HPV, as defined by
PCR, were common, and found in 53% of female
attendees of an urban STD clinic in Mongolia.
Many (74%) were single-pathogen infections.
With the exclusion of HPV, infections with
gonorrhea, chlamydia and trichomonas collec-
tively affected 37% of the populationstudied. This
isa highrate,particularlywhen itisconsideredthat
conventional STIs increase the risk of human
immunodeficiency virus (HIV) transmission10.
These findings are consistent with those recently
reported in a study using conventional diagnostic
methods, in a similar patient population2.
Therefore, it is imperative that effective strategies
be introduced in Mongolia to reduce the overall
prevalence of STIs. Currently, it is reported that
since HIV testing was introduced in Mongolia
(1987), onlyonecase of HIV has been recognized1
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Alone (n) Mixed with ‡1 other pathogen(s) (n) Total (n)
Chlamydia trachomatis
Neisseria gonorrhoeae
Trichomonas vaginalis
Human papillomavirus
Any pathogen
No pathogen detected
6
5
4
28
43
NA
9
7
5
11
15
NA
15 (14%)
12 (11%)
9 (8%)
39 (36%)
58 (53%)
52 (47%)
NA, not applicable
Table 1 Pathogens found in genital samples of women attendees at sexually transmitted diseases (STD) clinic,
Ulaanbaatar(and personal observation by C. Byambaa). How-
ever, HIV screening of attendees at STI clinics and
other high-risk behavior groups has not been uni-
versally offeredtosuch patients, andhencethetrue
incidence may be greater. With this relatively high
prevalence of bacterial and parasitic STIs in atten-
dees at an urbanSTDclinic, apotentiallyexplosive
situation exists with respect to HIV transmission,
should more cases exist in the community. With
the recent greater access to travel, Mongolians are
visiting countries where HIV is endemic; also,
with the influx of foreign travelers and business-
folk,thepotentialforspreadisenhanced.Strategies
to reduce STIs in general and those which are
culturally sensitive are vital.
Amplification assays such as PCR, when used
with minimal or noninvasive patient-collected
samples (tampon or first-voided urine), can
revolutionize STI testing, particularly for those
living in remote geographical areas 5,11,12. Such
assays have the advantage of the stability of nucleic
acid in the field, compared with conventional
assays which often suffer from transport delays and
conditions. Hence, despite the complexities of
performing amplification assays, patient-collected
samples can be transported to distant sites for
processing.
In addition to the conventional STIs of
N. gonorrhoeae, C. trachomatis and T. vaginalis,
human papillomavirus (HPV) was commonly
found (36%), with oncogenic genotypes being
present in 44% of positives. These findings under-
score the importance of a cervical cancer preven-
tion strategy, such as a Papanicolaou pre-cancer
cervical cytology screening program, which is
soon to be introduced.
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